لقاح ثلاثي
مراجع

1 2 3  "Is Vaccine Refusal Worth The Risk?". الإذاعة الوطنية العامة. National Public Radio. 26 مايو 2009. مؤرشف من الأصل في 2018-12-23. اطلع عليه بتاريخ 2009-06-19.
↑  "Vaccine Timeline: Historic Dates and Events Related to Vaccines and Immunization". Immunization Action Coalition. 17 مايو 2013. مؤرشف من الأصل في 2018-10-10. اطلع عليه بتاريخ 2014-06-25.
↑  "The difference between Tdap and DTaP; dabigatran versus warfarin". JAAPA. مؤرشف من الأصل في 2018-08-24. اطلع عليه بتاريخ 2014-06-25.
↑  Higgs, Higgins, Ross and Mills 2012 'Immunity to the respiratory pathogen Bordatella pertussis' Mucosal Immunol 5(5):485-500
↑  "Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel". MMWR Morb. Mortal. Wkly. Rep. ج. 55: 1–33. 15 ديسمبر 2016. مؤرشف من الأصل في 2019-05-08.
↑  "Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010". MMWR Morb. Mortal. Wkly. Rep. ج. 60 ع. 1: 13–5. يناير 2011. PMID:21228763. مؤرشف من الأصل في 2018-11-28.
↑  "Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012". MMWR Morb. Mortal. Wkly. Rep. ج. 62 ع. 7: 131–135. 22 فبراير 2013. مؤرشف من الأصل في 2019-03-28.
↑  Broder KR، Cortese MM، Iskander JK، وآخرون (مارس 2006). "Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep. ج. 55 ع. RR–3: 1–34. PMID:16557217. مؤرشف من الأصل في 2019-09-06., page 18.
↑  "ACIP Votes to Recommend Use of Combined Tetanus, Diphtheria and Pertussis (Tdap) Vaccine for Adults" (PDF). CDC.gov. مراكز مكافحة الأمراض واتقائها. مؤرشف من الأصل (PDF) في 2006-10-19.
↑  "Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis". PHAC-ASPC.GC.ca. مؤرشف من الأصل في 2006-09-27.
↑  Kretsinger K، Broder KR، Cortese MM، وآخرون (ديسمبر 2006). "Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel". MMWR Recomm Rep. ج. 55 ع. RR–17: 1–37. PMID:17167397. مؤرشف من الأصل في 2019-05-08.
↑  Bar-On ES، Goldberg E، Hellmann S، Leibovici L (2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". Cochrane Database Syst Rev. ج. 4 ع. 4: CD005530. DOI:10.1002/14651858.CD005530.pub3. PMID:22513932.
1 2 3 4 5  Health Care Guideline: Routine Prenatal Care. Fourteenth Edition. نسخة محفوظة June 24, 2012, على موقع واي باك مشين. By the Institute for Clinical Systems Improvement. July 2010.
↑  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months, 2011 - section "Safety of Tdap in Pregnant Women". By the Advisory Committee on Immunization Practices (ACIP), at مراكز مكافحة الأمراض واتقائها. نسخة محفوظة 26 يونيو 2017 على موقع واي باك مشين.
↑  "ACIP provisional updated recommendations on use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) for pregnant women" (PDF). مؤرشف من الأصل (PDF) في 2014-02-07.